Yues International Holdings Group Ltd. has announced the acquisition of Bozhou Lelaohao Medical Co., Ltd. The transaction involves Yues International, through its wholly owned subsidiary, acquiring 100% equity interest in the target company for a total consideration of RMB900,000. This acquisition aligns with Yues International's long-term strategic objectives and aims to enhance its market competitiveness. The company plans to address potential risks in pharmaceutical operations by optimizing supply chain management and enhancing quality control systems.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.